Kidneys from HIV donors may be OK for HIV patients, study finds
(HealthDay)—New research from South Africa suggests that HIV may not be a barrier for kidney transplants between people infected with the virus that causes AIDS.
Feb 11, 2015
0
31
(HealthDay)—New research from South Africa suggests that HIV may not be a barrier for kidney transplants between people infected with the virus that causes AIDS.
Feb 11, 2015
0
31
Findings of a three-year clinical trial led by University of Cincinnati (UC) transplant researchers suggest that a novel pre-operative drug therapy reduces antibodies in kidney patients with greater success than with traditional ...
Dec 23, 2014
0
0
A viral infection known as BK that commonly causes kidney transplant dysfunction in patients taking high doses of immunosuppressants may be treated with naturally occurring antibodies that already are widely available, according ...
Aug 1, 2014
0
0
A new Northwestern Medicine clinical trial aims to remove the need for organ transplant patients to take immunosuppressive drugs by increasing the number of their own regulatory T cells (T-regs). The first-in-human, Phase ...
Jun 30, 2014
0
0
A new data analysis technique could radically improve monitoring of kidney transplant patients, according to new research published this week in PLOS Computational Biology.
Jun 26, 2014
0
0
(HealthDay)—Survival rates for people with diabetes who have a kidney transplant are similar to those of people without diabetes, a new study finds.
May 9, 2014
0
0
Patients with highest levels of the most powerful version of the immune molecule HLA-G appear to have the lowest risk of rejecting their transplanted kidney, researchers report.
Apr 28, 2014
0
0
(Medical Xpress)—A study of over 750 kidney transplant patients over a five-year period conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that 90 percent of early rehospitalizations ...
Nov 1, 2013
0
0
(HealthDay)—Kidney transplant patients who develop a specific type of antibody response may be at particular risk of having the organ fail within a few years, a new study suggests.
Sep 25, 2013
0
0
A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham ...
Sep 25, 2013
0
0